+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

Small Fiber Neuropathy - Pipeline Insight, 2025 - Product Thumbnail Image

Small Fiber Neuropathy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Parenteral Nutrition Market Report 2025 - Product Thumbnail Image

Parenteral Nutrition Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Alpha V Beta 3/5/6 Integrin Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Alpha V Beta 3/5/6 Integrin Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Healthcare Supply Chain Management Market Report 2025 - Product Thumbnail Image

Healthcare Supply Chain Management Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Nrf2 Pathway Activators - Pipeline Insight, 2025 - Product Thumbnail Image

Nrf2 Pathway Activators - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Biopharmaceuticals Market Report and Forecast 2023-2031 - Product Thumbnail Image

Biopharmaceuticals Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 140 Pages
  • Global
From
From
AI Opportunities in Personalised Medicine - Product Thumbnail Image

AI Opportunities in Personalised Medicine

  • Report
  • March 2023
  • Global
From
Loading Indicator